Criteria for Justifying High-Entropy Complexity in Catalytic Cancer Therapy
High-entropy nanomaterials (HEMs) are advancing catalytic cancer therapy. The prevailing view treats entropy as a performance-enhancing design parameter, assuming it improves activity by broadening active-site chemistries. This review reframes that view as an oversimplification, positioning entropy as a contingent de...